| Title: |
A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer |
| Authors: |
Yoshioka, H. *, Katakami, N., Okamoto, H., Iwamoto, Y., Seto, T., Takahashi, T., Sunaga, N., Kudoh, S., Chikamori, K., Harada, M., Tanaka, H., Saito, H., Saka, H., Takeda, K., Nogami, N., Masuda, N., Harada, T., Kitagawa, H., Horio, H., Yamanaka, T., Fukuoka, M., Yamamoto, N., Nakagawa, K. |
| Source: |
In Annals of Oncology February 2017 28(2):285-291 |
| Database: |
ScienceDirect |
